1. Home
  2. CHR vs APVO Comparison

CHR vs APVO Comparison

Compare CHR & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheer Holding Inc.

CHR

Cheer Holding Inc.

HOLD

Current Price

$1.52

Market Cap

3.8M

Sector

Technology

ML Signal

HOLD

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

SELL

Current Price

$1.84

Market Cap

4.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CHR
APVO
Founded
2016
2016
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
4.3M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
CHR
APVO
Price
$1.52
$1.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 80.0K
40.9K
Earning Date
07-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 0.13
EPS
★ 0.06
N/A
Revenue
N/A
★ $3,114,000.00
Revenue This Year
$105.44
N/A
Revenue Next Year
$30.02
N/A
P/E Ratio
$25.83
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.53
52 Week High
$2.95
$10.70

Technical Indicators

Market Signals
Indicator
CHR
APVO
Relative Strength Index (RSI) 41.69 39.69
Support Level $1.51 $1.71
Resistance Level $1.69 $1.98
Average True Range (ATR) 0.13 0.09
MACD 0.00 0.05
Stochastic Oscillator 14.29 39.13

Price Performance

Historical Comparison
CHR
APVO

About CHR Cheer Holding Inc.

Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: